Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international

Dieter Haffner1, Franz Schaefer

  • 1Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany. haffner.dieter@mh-hannover.de

Insights

Optimal treatment for pediatric chronic kidney disease mineral and bone disorder (CKD-MBD) is crucial. A parathyroid hormone (PTH) range of 100-200 pg/ml is suggested for children on peritoneal dialysis.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Mineral and Bone Metabolism

Background:

  • Mineral and bone disorder (CKD-MBD) in pediatric chronic kidney disease (CKD) presents significant challenges.
  • Therapeutic goals include preventing skeletal complications, ensuring normal growth, and maintaining cardiovascular health.
  • Current pediatric guidelines for optimal parathyroid hormone (PTH) targets lack robust evidence and show considerable variation.

Purpose of the Study:

  • To review the evidence for optimal PTH target ranges in pediatric CKD patients.
  • To re-evaluate current guidelines using data from the International Pediatric Dialysis Network (IPPN) global registry.
  • To propose a reasonable PTH target range for children with CKD-MBD undergoing chronic peritoneal dialysis (PD).

Main Methods:

  • Analysis of clinical and biochemical data from the IPPN global registry, focusing on CKD-MBD in children on chronic PD.
  • Comprehensive evaluation of CKD-MBD outcome measures within this patient cohort.
  • Review of existing literature and current pediatric consensus guidelines.

Main Results:

  • The IPPN registry provides valuable data on CKD-MBD in pediatric PD patients.
  • Existing guidelines for PTH targets in pediatric CKD are based on limited evidence.
  • A PTH target range of 1.7-3 times the upper limit of normal (100-200 pg/ml) is identified as reasonable.

Conclusions:

  • The established PTH target range of 100-200 pg/ml is supported by the IPPN registry data for children on chronic PD.
  • This evidence-based range can aid in managing pediatric CKD-MBD.
  • Further research may refine targets, but this range offers a practical guideline.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...